These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6303528)

  • 41. Isolation and identification of hemin as an endogenous Na+/K(+)-ATPase inhibitor from porcine blood cells.
    Yasuhara T; Mori M; Wakamatsu K; Kubo K
    Biochem Biophys Res Commun; 1991 Jul; 178(1):95-103. PubMed ID: 1648917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High yield-purification of a urinary Na+-pump inhibitor.
    Cloix JF; Crabos M; Wainer IW; Ruegg U; Seiler M; Meyer P
    Biochem Biophys Res Commun; 1985 Sep; 131(3):1234-40. PubMed ID: 2996543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purification from human plasma of endogenous sodium transport inhibitor(s).
    Cloix JF; Dagher G; Crabos M; Pernollet MG; Meyer P
    Experientia; 1984 Dec; 40(12):1380-2. PubMed ID: 6096160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM
    Clin Exp Hypertens; 1998; 20(5-6):535-42. PubMed ID: 9682909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of guinea pig heart extracts with antidigoxin antibodies, ouabain binding site and Na,K-ATPase.
    Castañeda-Hernández G
    Proc West Pharmacol Soc; 1990; 33():9-13. PubMed ID: 2177197
    [No Abstract]   [Full Text] [Related]  

  • 46. Physiological inhibitors of Na, K-ATPase: concept and status.
    Haupert GT
    Prog Clin Biol Res; 1988; 268B():297-320. PubMed ID: 2851808
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of gossypol on Na+, K+ transmembrane fluxes in human red cells.
    Jin Y; Chen HC; Wo WH; Yang MZ; Xue SP
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(2):91-5. PubMed ID: 2798406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification, characterization and partial amino acid sequencing of a 70 kD inhibitor protein of Na+,K+-ATPase from goat testis cytosol.
    Mandal AK; Roy K; Sil PC; Yadav SP; Sen PC
    Mol Cell Biochem; 2001 Jul; 223(1-2):7-14. PubMed ID: 11681723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 75-kDa Na+,K+-ATPase competitive inhibitor protein isolated from rat brain cytosol binds to a site different from the ouabain-binding site.
    Roy K; Mandal AK; Sen PC
    Eur J Biochem; 1999 Apr; 261(1):84-8. PubMed ID: 10103037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics of Na+, K+-ATPase inhibition by an endogenous modulator (II-A).
    Reinés A; Peña C; Rodríguez de Lores Arnaiz G
    Neurochem Res; 2000 Jan; 25(1):121-7. PubMed ID: 10685611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a low molecular weight Na-K-ATPase inhibitor of urinary origin.
    Weiler EW; Gonick HC; Prins BA; Purdy RE; Weber MA
    Am J Med Sci; 1994 Jan; 307(1):27-35. PubMed ID: 8291503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Digitalis-like properties of an inhibitor of the Na+/K+ pump in human cerebrospinal fluid.
    Halperin JA
    J Neurol Sci; 1989 Apr; 90(2):217-30. PubMed ID: 2542468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetics of Na+, K+-ATPase inhibition by a rat brain endogenous factor (II-E).
    Herbin T; Peña C; Rodríguez de Lores Arnaiz G
    Neurochem Res; 1998 Jan; 23(1):33-7. PubMed ID: 9482264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of an inhibitor of the Na+/K+ pump in human cerebrospinal fluid.
    Halperin JA; Riordan JF; Tosteson DC
    J Biol Chem; 1988 Jan; 263(2):646-51. PubMed ID: 2826458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of 11,13-dihydroxy-14-octadecaenoic acid as a circulating Na+/K(+)-ATPase inhibitor.
    Lichtstein D; Samuelov S; Gati I; Felix AM; Gabriel TF; Deutsch J
    J Endocrinol; 1991 Jan; 128(1):71-8. PubMed ID: 1847965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor.
    Sancho JM; Garcia-Martin E; Garcia-Robles R; Santirso R; Villa E; Gutierrez-Merino C; Ricote M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S32-4. PubMed ID: 7508022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
    Inagami T; Tamura M
    Am J Med Sci; 1988 Apr; 295(4):400-5. PubMed ID: 2834953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine.
    Clarkson EM; de Wardener HE
    Clin Exp Hypertens A; 1985; 7(5-6):673-83. PubMed ID: 2990768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purification and characterization of endogenous digoxin-like immunoreactive factors in chicken blood.
    Wei JS; Cheng HC; Tsai KJ; Liu DH; Lee HH; Chiu DT; Liu TZ
    Life Sci; 1996; 59(19):1617-29. PubMed ID: 8913327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of extracts of rat brain on the digitalis receptor.
    Whitmer KR; Wallick ET; Epps DE; Lane LK; Collins JH; Schwartz A
    Life Sci; 1982 Jun; 30(26):2261-75. PubMed ID: 6287146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.